CTKB
HEALTHCARECytek BioSciences Inc
Live · NASDAQ · May 9, Close
What's Moving CTKB Today?
No stock-specific AI insight has been generated for CTKB yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$4.94
Fundamentals
Trading
CTKB News
20 articles- Cytek (CTKB) Q1 2026 Earnings Call TranscriptMotley Fool·May 8, 2026
- Cytek Biosciences, Inc. (CTKB) Reports Q1 Loss, Beats Revenue EstimatesYahoo Finance·May 7, 2026
- Cytek Biosciences Q1 Earnings Call HighlightsMarketbeat·May 7, 2026
- Cytek Biosciences Reports First Quarter 2026 Financial ResultsYahoo Finance·May 7, 2026
- AbCellera Biologics Among 3 Promising Penny StocksYahoo Finance·May 1, 2026
- Cytek Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026Yahoo Finance·Apr 23, 2026
- Cytek Biosciences (CTKB) Inspiring Confidence With Aurora CS System UpdatesYahoo Finance·Apr 14, 2026
- Nautilus Biotechnology And 2 Other Compelling Penny Stocks For Your WatchlistYahoo Finance·Mar 25, 2026
- Cytek® Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional ImpactYahoo Finance·Mar 9, 2026
- Cytek Biosciences Highlights Aurora Evo, Recurring Revenue Growth and 2026 Outlook at TD Cowen ConferenceMarketbeat·Mar 9, 2026
- How The Cytek Biosciences (CTKB) Story Is Shifting With New Targets And 2026 GuidanceYahoo Finance·Mar 9, 2026
- Cytek (CTKB) Q4 2025 Earnings Call TranscriptMotley Fool·Feb 27, 2026
- Cytek Biosciences, Inc. Q4 2025 Earnings Call SummaryMoby·Feb 27, 2026
- Cytek Biosciences Inc (CTKB) Q4 2025 Earnings Call Highlights: Record Revenue Amidst ChallengesYahoo Finance·Feb 27, 2026
- Cytek Biosciences Q4 Earnings Call HighlightsMarketbeat·Feb 27, 2026
- Cytek Biosciences, Inc. (CTKB) Reports Q4 Loss, Tops Revenue EstimatesYahoo Finance·Feb 27, 2026
- Cytek Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 OutlookYahoo Finance·Feb 26, 2026
- Cytek Biosciences to participate at the TD Cowen 46th Annual Health Care ConferenceYahoo Finance·Feb 18, 2026
- Cytek Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026Yahoo Finance·Feb 12, 2026
- This Cytek Biosciences Insider Increased Their Holding By 169% Last YearYahoo Finance·Feb 1, 2026
All 20 articles loaded
Price Data
52-Week Range
$4.94
Fundamentals
Trading
About Cytek BioSciences Inc
Cytek Biosciences Inc (CTKB) is a leading innovator in multi-parameter flow cytometry, delivering cutting-edge cell analysis solutions that are vital for advancements in the life sciences sector. Specializing in technologies that enhance cellular analyses, Cytek plays a significant role in research areas such as immunology, cancer diagnostics, and drug development. The company's commitment to innovation and exceptional customer service has established it as a key player in the biotechnology industry, effectively meeting the increasing demand for accurate and precise cell analysis tools. With a diverse product portfolio and a strong market presence, Cytek continues to push the boundaries of cell biology research, fostering breakthroughs that can transform healthcare outcomes.